glp-1 risk dvt Carrying excess weight is a known factor for blood clots, but could GLP -1 medications like Ozempic, Wegovy, and Mounjaro help lower that risk? New research suggests they might. Join us for Wegovy and Blood Clots: Do

4.5 Safety profile The safety assessment of GLP-1 receptor agonists indicates a mostly gastrointestinal side effect profile, characterised by dose-dependent symptoms that are often treatable by meticulous titration (Madsbad 2016)

we maintain the gold standard in Peptide Science by providing fully transparent documentation and laboratory-verified quality for every product in our catalog

This can be particularly beneficial for endurance athletes, such as runners or cyclists

No need to modify workout nutrition

Patients with ongoing injury history or who are returning to training after a setback may benefit from evaluation for combination therapy